EFFICACY AND SAFETY OF CRISABOROLE IN PATIENTS ≥3 MONTHS OF AGE WITH MILD-TO-MODERATE ATOPIC DERMATITIS (AD)

被引：0
|
作者：
Su, John C. [1 ]
Spelman, Lynda J. [2 ]
Eichenfield, Lawrence F. [3 ,4 ]
Gold, Linda F. Stein [5 ]
Cha, Amy [6 ]
Graham, Daniela [7 ]
Takiya, Liza [8 ]
Werth, John L. [9 ]
Zang, Chuanbo [10 ]
Vlahos, Bonnie [11 ]
机构：
[1] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia
[2] Verac Clin Res, Brisbane, Qld, Australia
[3] Univ Calif San Diego, Rady Childrens Hosp San Diego, Pediat & Adolescent Dermatol, San Diego, CA USA
[4] Univ Calif San Diego, Dept Dermatol & Pediat, San Diego, CA USA
[5] Henry Ford Hlth Syst, Dept Dermatol, Detroit, MI USA
[6] Pfizer Inc, Global Med Affairs Inflammat & Immunol, New York, NY USA
[7] Pfizer Inc, Hlth Econ & Outcomes Res Patient & Hlth Impact In, Collegeville, PA USA
[8] Pfizer Inc, North Amer Med Affairs Inflammat & Immunol, Collegeville, PA USA
[9] Pfizer Inc, Clin Dev & Operat, Collegeville, PA USA
[10] Pfizer Inc, Biostat, Collegeville, PA USA
[11] Pfizer Inc, Global Prod Dev Inflammat & Immunol, Collegeville, PA USA
来源：
ACTA DERMATO-VENEREOLOGICA | 2021年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
PT12
引用
收藏
页码：55 / 56
页数：2
相关论文
共 50 条
  • [31] Subgroup Analysis of Crisaborole for Mild-to-Moderate Atopic Dermatitis in Children Aged 2 to < 18 Years
    Thomas A. Luger
    Adelaide A. Hebert
    Andrea L. Zaenglein
    Jonathan I. Silverberg
    Huaming Tan
    William C. Ports
    Michael A. Zielinski
    Pediatric Drugs, 2022, 24 : 175 - 183
  • [32] Efficacy and safety trends with continuous long-term use of 2% crisaborole ointment in patients with mild to moderate atopic dermatitis
    Lebwohl, Mark G.
    Hebert, Adelaide A.
    Takiya, Liza
    Miller, Lauren E.
    Werth, John L.
    Zang, Chuanbo
    Sanders, Paul
    Geng, Bob
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB21 - AB21
  • [33] Crisaborole demonstrates improvement in quality of life in patients with mild to moderate atopic dermatitis
    Simpson, E.
    Paller, A.
    Boguniewicz, M.
    Eichenfield, L.
    Feldman, S.
    Silverberg, J.
    Chamlin, S.
    Zane, L.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 : 28 - 29
  • [34] Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1)
    Joel Schlessinger
    Julie S. Shepard
    Richard Gower
    John C. Su
    Charles Lynde
    Amy Cha
    William C. Ports
    Vivek Purohit
    Liza Takiya
    John L. Werth
    Chuanbo Zang
    Bonnie Vlahos
    American Journal of Clinical Dermatology, 2020, 21 : 275 - 284
  • [35] Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1)
    Schlessinger, Joel
    Shepard, Julie S.
    Gower, Richard
    Su, John C.
    Lynde, Charles
    Cha, Amy
    Ports, William C.
    Purohit, Vivek
    Takiya, Liza
    Werth, John L.
    Zang, Chuanbo
    Vlahos, Bonnie
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2020, 21 (02) : 275 - 284
  • [36] CRISABOROLE DEMONSTRATES IMPROVEMENT IN QUALITY OF LIFE IN PATIENTS WITH MILD TO MODERATE ATOPIC DERMATITIS
    Simpson, E.
    Paller, A.
    Boguniewicz, M.
    Eichenfield, L.
    Feldman, S.
    Silverberg, J.
    Chamlin, S.
    Zane, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S20 - S21
  • [37] Crisaborole Ointment 2%: A Review in Mild to Moderate Atopic Dermatitis
    Sheridan M. Hoy
    American Journal of Clinical Dermatology, 2017, 18 : 837 - 843
  • [38] A SYSTEMATIC LITERATURE REVIEW AND NETWORK META-ANALYSIS (NMA) OF CRISABOROLE 2% OINTMENT FOR THE TREATMENT OF MILD-TO-MODERATE ATOPIC DERMATITIS (AD)
    Fahrbach, K.
    Tarpey, J.
    Bergrath, E.
    Hughes, R.
    Cha, A.
    Gerber, R.
    Cappelleri, J. C.
    VALUE IN HEALTH, 2019, 22 : S597 - S598
  • [39] Crisaborole Ointment 2%: A Review in Mild to Moderate Atopic Dermatitis
    Hoy, Sheridan M.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2017, 18 (06) : 837 - 843
  • [40] Treatment preferences among patients with mild-to-moderate atopic dermatitis
    Myers, Kelley
    Silverberg, Jonathan I.
    Parasuraman, Shreekant
    Pierce, Anna
    Eichenfield, Lawrence F.
    Poulos, Christine
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
12345